A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 67, Issue 3, Pages 899-913
Publisher
Wiley
Online
2017-09-08
DOI
10.1002/hep.29513
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer
- (2017) W Zhou et al. GENE THERAPY
- A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA
- (2016) Cong Luo et al. BIOMATERIALS
- Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
- (2016) Lei Miao et al. CANCER RESEARCH
- Onto better TRAILs for cancer treatment
- (2016) D de Miguel et al. CELL DEATH AND DIFFERENTIATION
- Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells
- (2016) Yumin Oh et al. HEPATOLOGY
- Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs
- (2016) YING HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Local and transient gene expression primes the liver to resist cancer metastasis
- (2016) T. J. Goodwin et al. Science Translational Medicine
- Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma
- (2015) Yu Wang et al. Acta Biomaterialia
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
- (2015) Thomas Reiberger et al. Nature Protocols
- Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma
- (2015) Kui Wang et al. Advanced Healthcare Materials
- Getting TRAIL back on track for cancer therapy
- (2014) J Lemke et al. CELL DEATH AND DIFFERENTIATION
- Death receptor agonist therapies for cancer, which is the right TRAIL?
- (2013) Pamela M. Holland CYTOKINE & GROWTH FACTOR REVIEWS
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
- (2013) Virginia Hernandez–Gea et al. GASTROENTEROLOGY
- Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice
- (2013) Yunching Chen et al. HEPATOLOGY
- Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo
- (2012) Changyou Zhan et al. JOURNAL OF CONTROLLED RELEASE
- TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice
- (2012) Kathrin Steinwede et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adhesion receptors as therapeutic targets for circulating tumor cells
- (2012) Jiahe Li et al. Frontiers in Oncology
- Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
- (2011) Joan Fernando et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor
- (2011) Jun Li et al. JOURNAL OF CONTROLLED RELEASE
- TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation
- (2011) Emmet E. McGrath et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A Novel Combination Treatment of Armed Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Radiotherapy in Murine Hepatocarcinoma
- (2011) Wonwoo KIM et al. JOURNAL OF RADIATION RESEARCH
- Targeting Cell Spreading: A Method of Sensitizing Metastatic Tumor Cells to TRAIL-Induced Apoptosis
- (2011) L. E. Phipps et al. MOLECULAR CANCER RESEARCH
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
- (2011) Tom Luedde et al. Nature Reviews Gastroenterology & Hepatology
- Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: Involvement of Ca2+ influx
- (2011) Dong-Oh Moon et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- The Etiology of Hepatocellular Carcinoma and Consequences for Treatment
- (2010) A. J. Sanyal et al. ONCOLOGIST
- TRAIL Gene Therapy: From Preclinical Development to Clinical Application
- (2009) Thomas Griffith et al. CURRENT GENE THERAPY
- Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
- (2008) J. Ma et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search